Technical Specifications

• CAS Number: 218949-48-5
  
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
  
• Molecular Weight: ~5135.9 g/mol
  
• PubChem ID: 16132314
  
• Purity: ≥99% (HPLC tested)
  
• Form: Lyophilized powder
• Synthesis Method: Solid-phase peptide synthesis

Analytical & Testing

Each batch of Tesamorelin undergoes high-performance liquid chromatography (HPLC) and mass spectrometry (MS) analysis to verify purity, identity, and analytical consistency. A corresponding Certificate of Analysis (COA) is available for each batch.

Handling & Storage

This compound should be handled by qualified professionals in controlled laboratory environments. Proper storage conditions should be maintained to preserve compound stability and structural integrity.

Research Context

In preclinical and laboratory research models, Tesamorelin has been examined across endocrine, metabolic, and cellular systems. Research focus includes:

• Growth hormone–related signaling pathways
• IGF-1 associated activity models
• Endocrine pathway interactions
• Cellular-level signaling mechanisms

These observations are limited to controlled experimental environments and support ongoing laboratory investigations.

Research Application Scope

Tesamorelin continues to be evaluated for its relevance in experimental biology, particularly within studies involving hormonal signaling, endocrine pathway analysis, and cellular interaction models.

Use Statement

For laboratory research use only. Intended strictly for in vitro research applications.

Disclaimer

All products currently listed on this site are for research purposes ONLY.